PDB57 COST SAVINGS ASSOCIATED WITH PREMIX VERSUS BASAL-BOLUS REGIMEN IN ALGERIAN PATIENTS WITH TYPE 2 DIABETES INSUFFICIENTLY CONTROLLED UNDER BASAL INSULIN REGIMEN
Nov 1, 2019, 00:00
10.1016/j.jval.2019.09.939
https://www.valueinhealthjournal.com/article/S1098-3015(19)33317-0/fulltext
Title :
PDB57 COST SAVINGS ASSOCIATED WITH PREMIX VERSUS BASAL-BOLUS REGIMEN IN ALGERIAN PATIENTS WITH TYPE 2 DIABETES INSUFFICIENTLY CONTROLLED UNDER BASAL INSULIN REGIMEN
Citation :
https://www.valueinhealthjournal.com/action/showCitFormats?pii=S1098-3015(19)33317-0&doi=10.1016/j.jval.2019.09.939
First page :
Section Title :
Open access? :
No
Section Order :
10830